ClinicalTrials.Veeva

Menu

SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM

University of Pittsburgh logo

University of Pittsburgh

Status

Completed

Conditions

Adult PPSV Vaccinations
Adult Influenza Vaccinations
Adult Tdap/Td Vaccinations

Treatments

Behavioral: Pillar 4: Motivation
Behavioral: Pillar 1: Convenient Vaccination Services
Behavioral: Pillar 2: Patient notification
Behavioral: Pillar 3: Enhanced Office Systems

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT01868334
CDC-1U01IP000662-01

Details and patient eligibility

About

The purpose of this study is to test whether or not the 4 Pillars Toolkit increases adult Influenza, pneumococcal polysaccharide vaccine (PPSV), tetanus, adult diphtheria and acellular pertussis vaccine (Tdap/Td) vaccination rates. The vaccines are all FDA licensed vaccines and to be used according to national guidelines. The investigators will conduct a randomized cluster trial of this toolkit in diverse primary care practice with electronic medical records (EMRs).

Full description

This intervention is a two-region, two-year, stratified randomized cluster trial in 24 primary care practices with EMRs. These practices will be randomly assigned to be intervention or control sites to test this 4 Pillars Toolkit intervention package of evidence-based techniques tailored to their practice structure and culture; one set of practices randomized to intervention in year 1 and the other to control. In year 2, the other set of practices will receive the intervention and community controls may be sought.

These diverse practices consist of: 18 diverse practices from UPMC in western Pennsylvania and 6 diverse practices from large community health centers in a PBRN in Texas.

Enrollment

70,549 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Practice staff and adults in enrolled clinical sites

Inclusion Criteria:

Site inclusion criteria:

    1. an appropriate adult population: e.g., adults aged 50 years and older;
    1. currently using an EMR that has prompt ability, such as EpicCare;
    1. having and keeping immunization data within this EMR

Patient-level inclusion criteria:

    1. Adults (18 years and above) who are active patients of the enrolled practices (e.g., active patients are those with a visit within the last 12 months)
    1. All unvaccinated adults without a contraindication are eligible to receive Td/Tdap and influenza, regardless of age and at age 65 years or older are eligible for PPSV.

Exclusion Criteria:

Site exclusion criteria:

    1. consistent SOP use for the 3 vaccines being studied or high vaccination rates (e.g., 80%)

Patient-level exclusion criteria:

    1. those with a true contraindication, following the CDC's Guide to Contraindications (attached with the US Recommended Adult Immunization Schedule), such as prior vaccine anaphylaxis.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

70,549 participants in 2 patient groups

Intervention with the Toolkit
Experimental group
Description:
Pillar 1: Convenient Vaccination Services Pillar 2: Patient notification Pillar 3: Enhanced Office Systems Pillar 4: Motivation 13 clinical practices (intervention sites) will receive the Toolkit in Year 1 to increase their adult influenza, PPSV, Tdap/Td vaccination rates. In Year 2, those who choose to continue will "maintain" use of the Toolkit and online resources available but will receive no active intervention from study staff.
Treatment:
Behavioral: Pillar 2: Patient notification
Behavioral: Pillar 1: Convenient Vaccination Services
Behavioral: Pillar 4: Motivation
Behavioral: Pillar 3: Enhanced Office Systems
12 clinical practices (control sites)
No Intervention group
Description:
12 diverse clinical practices will receive no additional assistance in Year 1 to increase their adult influenza, PPSV, Tdap/Td vaccination rates, they will follow guidelines for usual care. In Year 2 however they will become intervention sites and receive the 4 Pillars Toolkit for use in increasing vaccination rates

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems